Stay updated on Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-06T16:36:48.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Added new disease terms (primary peritoneal carcinoma and fallopian tube cancer) and new resources (Genetic and Rare Diseases Information Center; MedlinePlus Genetics). Updated the page revision from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-13T01:28:27.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; no user-visible changes to study details or page behavior. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T12:46:15.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The explicit 'Ovarian cancer' topic and the 'MedlinePlus Genetics' related topics have been removed.
    Difference
    0.1%
    Check dated 2026-01-29T08:01:16.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4, a minor maintenance update with no changes to core study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T03:06:24.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Locations sections were reorganized: a general Locations entry was added with multiple regional sites (Arizona, California, Connecticut, New York, Ohio, Oregon, Tennessee, Texas, Virginia, Washington, Victoria, MI, RM) and the page was updated to Revision: v3.3.3. Several individual location subsections were removed, and the HHS Vulnerability Disclosure link was deleted.
    Difference
    0.9%
    Check dated 2025-12-24T16:53:53.000Z thumbnail image

Stay in the know with updates to Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page.